• In March 2024, Dexcom's Stelo, the initial glucose biosensor authorized by the FDA for non-prescription use in the U.S., is intended for individuals aged 18 and above not undergoing insulin treatment.

• In September 2023, Dexcom Canada and RxFood Corporation announced a partnership in Canada to launch an advanced digital health solution for people with diabetes.

• In September 2023, Abbott's acquisition of Bigfoot Biomedical advances its commitment to developing personalized, connected solutions for individuals with diabetes.

In this report, the Global Glucose Biosensors Market has been segmented by Product, Technology, Type, End Use and Geography.

Global Glucose Biosensors Market, Segmentation by Product

The Global Glucose Biosensors Market has been segmented by Product Continuous Glucose Monitoring, Self-monitoring Blood Glucose, and Non-invasive Glucose Monitoring.

Continuous glucose monitoring systems have transformed diabetes management by providing real-time glucose readings. In recent years, North America has led the global CGM market, commanding approximately 38% of the market share. The market is expected to grow significantly, reaching nearly 47.1% by 2034, driven by a 16% CAGR. This growth stems from the rising prevalence of diabetes and growing adoption of advanced monitoring technologies.

Self-monitoring blood glucose devices are essential for day-to-day blood glucose tracking, enabling users to conveniently manage their diabetes. The global SMBG market was valued at approximately USD 19.8 billion in 2024 and is projected to reach nearly USD 58.9 billion by 2034, with an anticipated CAGR of around 11.8%. This expansion is fueled by the growing diabetic population and emphasis on regular monitoring for effective management.

Non-invasive glucose monitoring technologies are rapidly gaining popularity for their pain-free and user-friendly approach. The global non-invasive glucose monitoring market was valued at around USD 195 million in 2024 and is projected to reach approximately USD 379 million by 2032, growing at a CAGR of about 8.65%. In 2024, wearable devices dominated the market, capturing approximately 56.5% share, reflecting the rising preference for comfortable and continuous monitoring solutions.

Global Glucose Biosensors Market, Segmentation by Technology

The Global Glucose Biosensors Market has been segmented by Technology into Electrochemical Biosensors, and Optical Biosensors.

Electrochemical Biosensors

Electrochemical biosensors continue to lead the global glucose biosensor market, capturing about 85% of the total share. Their popularity stems from their excellent sensitivity, affordability, and quick response times, making them a preferred choice in medical and diagnostic applications. These devices convert the biochemical reaction between glucose and a specific enzyme into measurable electrical signals, ensuring reliable and real-time glucose monitoring.

Optical Biosensors

Optical biosensors hold approximately 15% of the market share, offering a precise and non-invasive glucose measurement solution. They utilize light-based signals to detect glucose levels, making them particularly valuable for continuous monitoring devices. The reduced risk of interference and higher specificity of these sensors set them apart from electrochemical alternatives.

Global Glucose Biosensors Market, Segmentation by Type

The Global Glucose Biosensors Market has been segmented by Type into Electrochemical, Optical and Others.

Electrochemical

Electrochemical biosensors dominate the global glucose biosensors market with an estimated 85% market share. Known for their quick response times, affordability, and reliability, they have become the standard in personal and clinical glucose monitoring solutions. These sensors translate the chemical reaction between glucose and enzymes into measurable electrical signals for real-time monitoring.

Optical

Optical biosensors hold roughly 10% of the market share, offering a highly specific and non-invasive alternative for glucose monitoring. Utilizing light-based detection methods, they provide continuous glucose readings with reduced interference, making them ideal for wearable technologies and long-term monitoring.

Others

Other biosensor types, such as piezoelectric and thermal biosensors, collectively account for approximately 5% of the market. While still in early stages of adoption, these technologies show promise with advantages like multi-analyte detection capabilities and greater stability under varying conditions.

Global Glucose Biosensors Market, Segmentation by End Use

The Global Glucose Biosensors Market has been segmented by End Use into Hospitals, Homecare and Diagnostic centers.

Hospitals

Hospitals account for approximately 55% of the global glucose biosensors market, leveraging these devices for continuous and precise glucose monitoring of patients. With a focus on real-time and accurate results, glucose biosensors have become indispensable in managing critical care and diabetes patients in clinical settings.

Homecare

Homecare represents about 30% of the glucose biosensor market, reflecting the growing trend of self-monitoring by individuals with diabetes. The convenience and portability of glucose biosensors make them an essential tool for personal glucose tracking, enabling proactive health management at home.

Diagnostic Centers

Diagnostic centers contribute roughly 15% to the glucose biosensors market. These facilities rely on glucose biosensors for accurate and efficient glucose testing during routine diagnostics. Their use ensures timely detection and management of abnormal glucose levels, supporting early intervention and ongoing patient care.

Global Glucose Biosensors Market, Segmentation by Geography

In this report, the Global Glucose Biosensors Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Glucose Biosensors Market Share (%), by Geographical Region, 2024

Hospitals

Hospitals account for approximately 55% of the global glucose biosensors market, leveraging these devices for continuous and precise glucose monitoring of patients. With a focus on real-time and accurate results, glucose biosensors have become indispensable in managing critical care and diabetes patients in clinical settings.

Homecare

Homecare represents about 30% of the glucose biosensor market, reflecting the growing trend of self-monitoring by individuals with diabetes. The convenience and portability of glucose biosensors make them an essential tool for personal glucose tracking, enabling proactive health management at home.

Diagnostic Centers

Diagnostic centers contribute roughly 15% to the glucose biosensors market. These facilities rely on glucose biosensors for accurate and efficient glucose testing during routine diagnostics. Their use ensures timely detection and management of abnormal glucose levels, supporting early intervention and ongoing patient care.